Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 10, keine Gesamtzahl für „Reaction“
Suchtreffer
Begriffe & Kennungen
Accofil · 4.8 · 69 MedDRA Adverse reactions system Very common Common Uncommon Rare organ class (≥ 1/10) (≥ 1/100 to < (≥ 1/1,
Eintrag öffnenAccofil · 4.8 · Hypersensitivity Hypersensitivity-type reactions including anaphylaxis, rash, urticaria, angioedema, dyspnoea
Eintrag öffnenAccofil · 4.8 · Hypersensitivity Hypersensitivity-type reactions including anaphylaxis, rash, urticaria, angioedema, dyspnoea
Eintrag öffnenAccofil · 4.8 · Hypersensitivity Hypersensitivity-type reactions including anaphylaxis, rash, urticaria, angioedema, dyspnoea
Eintrag öffnenAccofil · 4.8 · Hypersensitivity Hypersensitivity-type reactions including anaphylaxis, rash, urticaria, angioedema, dyspnoea
Eintrag öffnenAccofil · 4.8 · MedDRA Adverse reactions system Very common Common Uncommon Rare organ class (≥ 1/10) (≥ 1/100 to < (≥ 1/1,000
Eintrag öffnenAccofil · 4.8 · MedDRA Adverse reactions system Very common Common Uncommon Rare organ class (≥ 1/10) (≥ 1/100 to < (≥ 1/1,000
Eintrag öffnenAccofil · 4.8 · MedDRA Adverse reactions system Very common Common Uncommon Rare organ class (≥ 1/10) (≥ 1/100 to < (≥ 1/1,000
Eintrag öffnenAccofil · 4.8 · MedDRA Adverse reactions system Very common Common Uncommon Rare organ class (≥ 1/10) (≥ 1/100 to < (≥ 1/1,000
Eintrag öffnenAccofil · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenAccofil · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenAccofil · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenAccofil · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenAccofil · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenAccofil · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenAccofil · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenAccofil · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenAccofil · 4.8 · The data in the table below describe adverse reactions reported from clinical trials and spontaneous reporting
Eintrag öffnenAccofil · 4.8 · The data in the table below describe adverse reactions reported from clinical trials and spontaneous reporting
Eintrag öffnenAccofil · 4.8 · The data in the table below describe adverse reactions reported from clinical trials and spontaneous reporting
Eintrag öffnen